LISSONI, ANDREA ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 111
EU - Europa 17
AS - Asia 5
Totale 133
Nazione #
US - Stati Uniti d'America 111
IT - Italia 7
DE - Germania 3
NL - Olanda 3
CN - Cina 2
VN - Vietnam 2
GB - Regno Unito 1
IE - Irlanda 1
IN - India 1
MK - Macedonia 1
UA - Ucraina 1
Totale 133
Città #
Santa Cruz 18
Fairfield 15
Seattle 8
Houston 6
Ashburn 5
Chicago 5
Buffalo 4
Cambridge 4
Wilmington 3
Woodbridge 3
Milan 2
Provo 2
Sesto Fiorentino 2
Ann Arbor 1
Bengaluru 1
Boardman 1
Brooklyn 1
Clearwater 1
Denver 1
Dong Ket 1
Dublin 1
Fleming Island 1
Frankfurt am Main 1
Groningen 1
Herndon 1
Kenmore 1
Kirkland 1
Los Angeles 1
Miami 1
New Kensington 1
Ravenna 1
San Diego 1
Shanghai 1
Winchester 1
Totale 98
Nome #
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer, file e39773b7-9172-35a3-e053-3a05fe0aac26 56
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential, file e39773b7-96c3-35a3-e053-3a05fe0aac26 47
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial, file e39773b7-9af9-35a3-e053-3a05fe0aac26 33
Clinically oriented three-step strategy to the assessment of adnexal pathology, file e39773b2-fd18-35a3-e053-3a05fe0aac26 1
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy, file e39773b3-8e97-35a3-e053-3a05fe0aac26 1
Totale 138
Categoria #
all - tutte 417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 2 10 8 8 1
2021/202258 5 6 1 3 7 0 5 2 2 1 20 6
2022/202347 0 5 17 4 2 6 2 0 3 3 5 0
2023/20242 1 0 1 0 0 0 0 0 0 0 0 0
Totale 138